Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx

European Journal of Clinical Investigation

Volumn 45, Issue 11, 2015, Pages 1129-1144

  Herencia, Carmen ^a   Rodríguez Ortiz, M Encarnacion ^b,c   Muñoz Castañeda, Juan R ^a   Martinez Moreno, Julio Manuel ^a   Canalejo, Rocío ^d   Montes de Oca, Addy ^a   Díaz Tocados, Juan M ^a   Peralbo Santaella, Esther ^a   Marín, Carmen ^a,e   Canalejo, Antonio ^d   Rodriguez, Mariano ^a,c   Almaden, Yolanda ^a,e  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b UAM)   (Spain)

^c REDINREN   (Spain)

^d UNIVERSITY OF HUELVA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Angiotensin II; Chronic kidney disease; Magnesium; Transient receptor potential melastatin 7; Vascular calcification; Wnt beta catenin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 AMINOETHOXYDIPHENYLBORANE; ALKALINE PHOSPHATASE; ANGIOTENSIN II; BETA CATENIN; BIOCHEMICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; DICKKOPF 1 PROTEIN; LOSARTAN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MAGNESIUM; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7; 2-AMINOETHOXYDIPHENYL BORATE; BMP2 PROTEIN, HUMAN; BORON DERIVATIVE; PROTEIN SERINE THREONINE KINASE; RUNX2 PROTEIN, HUMAN; SP7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, HUMAN; VASOCONSTRICTOR AGENT;

ARTICLE; BLOOD VESSEL CALCIFICATION; CELL TRANSDIFFERENTIATION; CHRONIC KIDNEY DISEASE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IC50; IMMUNOFLUORESCENCE; LUCIFERASE ASSAY; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING; WNT SIGNALING PATHWAY; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ALKALINE PHOSPHATASE; ANGIOTENSIN II; BONE MORPHOGENETIC PROTEIN 2; BORON COMPOUNDS; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; MAGNESIUM; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRPM CATION CHANNELS; UP-REGULATION; VASCULAR CALCIFICATION; VASOCONSTRICTOR AGENTS; WNT SIGNALING PATHWAY;

EID: 84945492509     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12517     Document Type: Article

References (51)

1. Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL et al. Vascular calcification in chronic kidney disease. Clin Sci 2010;119:111-21.
2. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009;75:890-7.
3. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001;103:1529-34.
4. Briet M, Burns KD. Chronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications. Clin Sci 2012;123:399-416.
5. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008;19:213-6.
6. Ishimura E, Okuno S, Kitatani K, Tsuchida T, Yamakawa T, Shioi A et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 2007;68:222-7.
7. Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int 2014;85:174-81.
8. Montezano AC, Zimmerman D, Yusuf H, Burger D, Chignalia AZ, Wadhera V et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010;56:453-62.
9. Louvet L, Büchel J, Steppan S, Passlick-Deetjen J, Massy ZA Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant 2013;28:869-78.
10. Kircelli F, Peter ME, Sevinc Ok E, Celenk FG, Yilmaz M, Steppan S et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012;27:514-21.
11. Montes de Oca A, Guerrero F, Martinez-Moreno JM, Madueño JA, Herencia C, Peralta A et al. Magnesium inhibits Wnt/beta-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells. PLoS ONE 2014;9:e89525.
12. He Y, Yao G, Savoia C, Touyz RM Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res 2005;96:207-15.
13. Liu Y, Zhou YB, Zhang GG, Cai Y, Duan XH, Teng X et al. Cortistatin attenuates vascular calcification in rats. Regul Pept 2010;159:35-43.
14. Armstrong ZB, Boughner DR, Drangova M, Rogers KA. Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model. Cardiovasc Res 2011;90:165-70.
15. 1 receptor signaling cascades in cardiovascular physiopathology. Cell Signal 2014;26:2147-60.
16. Kato H, Fukami K, Shibasaki F, Homma Y, Takenawa T. Enhancement of phospholipase C delta 1 activity in the aortas of spontaneously hypertensive rats. J Biol Chem 1992;267:6483-7.
17. O'Brien KD, Probstfield JL, Caulfield MT, Nasir K, Takasu J, Shavelle DM et al. Angiotensin-converting enzyme inhibitors and change in aortic valve calcium. Arch Intern Med 2005;165:858-62.
18. Osako MK, Nakagami H, Shimamura M, Koriyama H, Nakagami F, Shimizu H et al. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification. Arterioscler Thromb Vasc Biol 2013;33:1287-96.
19. Anand DV, Lim E, Darko D, Bassett P, Hopkins D, Lipkin D et al. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J Am Coll Cardiol 2007;50:2218-25.
20. Tokumoto M, Mizobuchi M, Finch JL, Nakamura H, Martin DR, Slatopolsky E. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification. Am J Nephrol 2009;29:582-91.
21. Patidar A, Singh DK, Winocour P, Farrington K, Baydoun AR. Human uraemic serum displays calcific potential in vitro that increases with advancing chronic kidney disease. Clin Sci 2013;125:237-45.
22. Martínez-Moreno JM, Muñoz-Castañeda JR, Herencia C, Oca AM, Estepa JC, Canalejo R et al. In vascular smooth muscle cells paricalcitol prevents phosphate-induced Wnt/β-catenin activation. Am J Physiol Renal Physiol 2012;303:F1136-44.
23. Shalhoub V, Shatzen E, Henley C, Boedigheimer M, McNinch J, Manoukian R et al. Calcification inhibitors and Wnt signaling proteins are implicated in bovine artery smooth muscle cell calcification in the presence of phosphate and vitamin D sterols. Calcif Tissue Int 2006;79:431-42.
24. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20.
25. Zucchini-Pascal N, Peyre L, Rahmani R. Crosstalk between beta-catenin and snail in the induction of epithelial to mesenchymal transition in hepatocarcinoma: role of the ERK1/2 pathway. Int J Mol Sci 2013;14:20768-92.
26. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H. Vascular calcification and inorganic phosphate. Am J Kidney Dis 2001;4:S34-347.
27. Demer LL, Tintut Y. Vascular calcification: pathobiology of multifaceted disease. Circulation 2008;117:2938-48.
28. Nakashima H, Suzuki H, Ohtsu H, Chao JY, Utsunomiya H, Frank GD. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol 2006;4:67-78.
29. Zhang Z, Wang M, Fan XH, Chen JH, Guan YY, Tang YB. Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta. Circ Res 2012;111:1137-46.
30. Nie B, Zhou S, Fang X, Li W, Wang B, Guan S. Implication of receptor activator of NF-κB ligand in Wnt/β-catenin pathway promoting osteoblast-like cell differentiation. J Huazhong Univ Sci Technolog Med Sci 2012;32:818-22.
31. Zhang J, Fu M, Myles D, Zhu X, Du J, Cao X et al. PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. FEBS Lett 2002;52:180-4.
32. Hautmann MB, Thompson MM, Swartz EA, Olson EN, Owens GK. Angiotensin II-induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor MHox. Circ Res 1997;81:600-10.
33. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002;106:1192-4.
34. Zhou S, Fang X, Xin H, Li W, Qiu H, Guan S. Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the Notch1-RBP-Jκ/Msx2 signaling pathway. PLoS ONE 2013;8:e68987.
35. Wang CC, Sorribas V, Sharma G, Levi M, Draznin B. Insulin attenuates vascular smooth muscle calcification but increases vascular smooth muscle cell phosphate transport. Atherosclerosis 2007;195:e65-75.
36. Kaplan-Albuquerque N, Garat C, Van Putten V, Nemenoff RA. Regulation of SM22 alpha expression by arginine vasopressin and PDGF-BB in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 2003;285:H1444-52.
37. Huang Z, Li J, Jiang Z, Qi Y, Tang C, Du J. Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 2003;42:89-97.
38. Shin V, Zebboudj AF, Bostrom K. Endothelial cells modulate osteogenesis in calcifying vascular cells. J Vasc Res 2004;41:193-201.
39. Johnstone MT, Perez AS, Nasser I, Stewart R, Vaidya A, Al Ammary F et al. Angiotensin receptor blockade with candesartan attenuates atherosclerosis, plaque disruption, and macrophage accumulation within the plaque in a rabbit model. Circulation 2004;110:2060-5.
40. Matsushita K, Wu Y, Pratt RE, Dzau VJ. Blockade of angiotensin II type 2 receptor by PD123319 inhibits osteogenic differentiation of human mesenchymal stem cells via inhibition of extracellular signal-regulated kinase signaling. J Am Soc Hypertens 2015;9:517-25.
41. Xie C, Shen Y, Hu W, Chen Z, Li Y. Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts. Aging Clin Exp Res 2015; doi: 10.1007/s40520-015-0408-2. [Epub ahead of print].
42. Suski M, Gebska A, Olszanecki R, Stachowicz A, Uracz D, Madej J et al. Influence of atorvastatin on angiotensin I metabolism in resting and TNF-α-activated rat vascular smooth muscle cells. J Renin Angiotensin Aldosterone Syst 2014;15:378-83.
43. Sui YB, Chang JR, Chen WJ, Zhao L, Zhang BH, Yu YR et al. Angiotensin-(1-7) inhibits vascular calcification in rats. Peptides 2013;42:25-34.
44. Albinsson S, Sessa WC. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics 2011;43:529-33.
45. Xie C, Zhang J, Chen YE. MicroRNA and vascular smooth muscle cells. Vitam Horm 2011;87:321-39.
46. Goettsch C, Rauner M, Pacyna N, Hempel U, Bornstein SR, Hofbauer LC. miR-125b regulates calcification of vascular smooth muscle cells. Am J Pathol 2011;179:1594-600.
47. Chen NX, Kiattisunthorn K, O'Neill KD, Chen X, Moorthi RN, Gattone VH 2nd et al. Decreased microRNA is involved in the vascular remodeling abnormalities in chronic kidney disease (CKD). PLoS ONE 2013;8:e64558.
48. Wen P, Cao H, Fang L, Ye H, Zhou Y, Jiang L et al. miR-125b/Ets1 axis regulates transdifferentiation and calcification of vascular smooth muscle cells in a high-phosphate environment. Exp Cell Res 2014;322:302-12.
49. Chaturvedi P, Chen NX, O'Neill K, McClintick JN, Moe SM, Janga SC. Differential miRNA Expression in Cells and Matrix Vesicles in Vascular Smooth Muscle Cells from Rats with Kidney Disease. PLoS ONE 2015;10:e0131589.
50. Panizo S, Naves-Díaz M, Carrillo-López N, Martínez-Arias L, Fernández-Martín JL, Ruiz-Torres MP et al. MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus. J Am Soc Nephrol 2015; doi: 10.1681/ASN.2014050520. [Epub ahead of print]
51. Gui T, Zhou G, Sun Y, Shimokado A, Itoh S, Oikawa K et al. MicroRNAs that target Ca(2+) transporters are involved in vascular smooth muscle cell calcification. Lab Invest 2012;92:1250-9.